000 01473 a2200397 4500
005 20250517172334.0
264 0 _c20191104
008 201911s 0 0 spa d
022 _a1578-1275
024 7 _a10.1016/j.aprim.2017.04.006
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDubois Marques, Daniela
245 0 0 _a[Fine-tuning of antithrombotic therapy in patients with non-valvular atrial fibrillation. The AFINVA register].
_h[electronic resource]
260 _bAtencion primaria
_c
300 _a340-349 p.
_bdigital
500 _aPublication Type: Journal Article; Observational Study
650 0 4 _aAged
650 0 4 _aAnticoagulants
_xtherapeutic use
650 0 4 _aAtrial Fibrillation
_xcomplications
650 0 4 _aFibrinolytic Agents
_xtherapeutic use
650 0 4 _aGuideline Adherence
650 0 4 _aHumans
650 0 4 _aHypothyroidism
_xcomplications
650 0 4 _aMyocardial Ischemia
_xcomplications
650 0 4 _aPlatelet Aggregation Inhibitors
_xtherapeutic use
650 0 4 _aPrevalence
650 0 4 _aProspective Studies
650 0 4 _aStroke
_xprevention & control
700 1 _aMora Llabata, Vicente
700 1 _aPacheco Arroyo, Julián
700 1 _aGasull Insertis, Salvador
700 1 _aVicente Cañizares, Manuela
700 1 _aRoldán Torres, Ildefonso
773 0 _tAtencion primaria
_gvol. 50
_gno. 6
_gp. 340-349
856 4 0 _uhttps://doi.org/10.1016/j.aprim.2017.04.006
_zAvailable from publisher's website
999 _c27523336
_d27523336